We've been engaged in discussions with China for the last several months because, as you know, they also have a very active vaccine development programme and several of their vaccine candidates are in advanced stages of clinical trial so this is also of interest to us so we're following those very closely.
Tumehusika na mjadala na Uchina kwa miezi mingi iliyopita kwa sababu,mnavyojua, hao pia wanao programu amilifu ya kukuza chanjo na na chanjo zao mingi ziko hatua mbele ya majaribio ya kliniki, huu ni maslahi kwetu,kwa hivyo tunafuatilia kwa karibu.